share_log

Wedbush Downgrades Surface Oncology to Neutral

Benzinga ·  Jun 20, 2023 09:06

Wedbush analyst Robert Driscoll downgrades Surface Oncology (NASDAQ:SURF) from Outperform to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment